Takarazuka, Japan

Shigeru Kamei



Average Co-Inventor Count = 3.5

ph-index = 11

Forward Citations = 657(Granted Patents)


Location History:

  • Hyogo, JP (1997)
  • Takarazuka, JP (1993 - 2007)

Company Filing History:


Years Active: 1993-2007

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Shigeru Kamei: Innovator in Sustained-Release Preparations

Introduction

Shigeru Kamei is a prominent inventor based in Takarazuka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release preparations. With a total of 14 patents to his name, Kamei's work has had a substantial impact on drug delivery systems.

Latest Patents

Among his latest patents is a sustained-release preparation for angiotensin II antagonists. This invention provides a stable and active formulation that maintains the circadian rhythm of blood pressure over an extended period. Another notable patent involves a sustained-release preparation that includes a physiologically active peptide, designed to release the peptide consistently without an initial burst, ensuring prolonged efficacy.

Career Highlights

Kamei has worked with notable companies such as Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to groundbreaking research.

Collaborations

Throughout his career, Kamei has collaborated with esteemed colleagues, including Yasutaka Igari and Yasuaki Ogawa. These partnerships have fostered a collaborative environment that has led to significant advancements in their respective fields.

Conclusion

Shigeru Kamei's contributions to sustained-release preparations exemplify his dedication to innovation in pharmaceuticals. His patents reflect a commitment to improving drug delivery systems, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…